Literature DB >> 8626654

Alpha-tocopherol as a reductant for Cu(II) in human lipoproteins. Triggering role in the initiation of lipoprotein oxidation.

A Kontush1, S Meyer, B Finckh, A Kohlschütter, U Beisiegel.   

Abstract

Initiation of lipid peroxidation by Cu(II) requires reduction of Cu(II) to Cu(I) as a first step. It is unclear, however, whether this reaction occurs in the course of lipoprotein oxidation. It is also unknown which reductant, if any, can drive the reduction of Cu(II) in this case. We found that Cu(II) was rapidly reduced to Cu(I) by all major human lipoproteins (high, low, and very low density lipoproteins (HDL, LDL, and VLDL), and chylomicrons). Cu(II)-reducing activity was associated with a lipid moiety of the lipoproteins. The rates of Cu(II) reduction by different lipoproteins were similar when the lipoproteins were adjusted to similar alpha-tocopherol concentrations. Enriching lipoproteins with alpha-tocopherol considerably increased the rate of CU(II) reduction. CU(II) reduction by alpha-tocopherol-deficient LDL isolated from a patient with familial inherited vitamin E deficiency was found to occur much slower in comparison with LDL isolated from a donor with a normal plasma level of alpha-tocopherol. Initial rate of CU(II) reduction by alpha-tocopherol-deficient LDL was found to be zero. Enriching LDL with ubiquinol-10 to concentrations close to those of alpha-tocopherol did not influence the reaction rate. When LDL was treated with ebselen to eliminate preformed lipid hydroperoxides, the reaction rate was also not changed significantly. CU(II) reduction was accompanied by a consumption of lipoprotein alpha-tocopherol and accumulation of conjugated dienes in the samples. Increasing alpha-tocopherol content in lipoproteins slightly decreased the rate of conjugated diene accumulation in LDL and HDL and considerably increased it in VLDL. The results suggest that alpha-tocopherol plays a triggering role in the lipoprotein oxidation by CU(II), providing its initial step as follows: alpha TocH + CU(II) --> alpha Toc. + Cu(I) + H+. This reaction appears to diminish or totally eliminate the antioxidative activity of alpha-tocopherol in the course of lipoprotein oxidation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8626654     DOI: 10.1074/jbc.271.19.11106

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  6 in total

1.  When and why a water-soluble antioxidant becomes pro-oxidant during copper-induced low-density lipoprotein oxidation: a study using uric acid.

Authors:  M Bagnati; C Perugini; C Cau; R Bordone; E Albano; G Bellomo
Journal:  Biochem J       Date:  1999-05-15       Impact factor: 3.857

2.  An (1)O2 route to γ-hydroxyalkenal phospholipids by vitamin E-induced fragmentation of hydroperoxydiene-derived endoperoxides.

Authors:  Xiaodong Gu; Wujuan Zhang; Jaewoo Choi; Wei Li; Xi Chen; James M Laird; Robert G Salomon
Journal:  Chem Res Toxicol       Date:  2011-05-31       Impact factor: 3.739

3.  Cu2+ -induced low density lipoprotein peroxidation is dependent on the initial O2 concentration: an O2 consumption study.

Authors:  J K Lodge; M G Traber; P J Sadler
Journal:  Lipids       Date:  2000-10       Impact factor: 1.880

4.  Contribution of copper binding to the inhibition of lipid oxidation by plasmalogen phospholipids.

Authors:  D Hahnel; T Huber; V Kurze; K Beyer; B Engelmann
Journal:  Biochem J       Date:  1999-06-01       Impact factor: 3.857

5.  Interactions between apolipoprotein E gene and dietary alpha-tocopherol influence cerebral oxidative damage in aged mice.

Authors:  E E Reich; K S Montine; M D Gross; L J Roberts; L L Swift; J D Morrow; T J Montine
Journal:  J Neurosci       Date:  2001-08-15       Impact factor: 6.167

6.  Lipid peroxidation of isolated chylomicrons and oxidative status in plasma after intake of highly purified eicosapentaenoic or docosahexaenoic acids.

Authors:  J B Hansen; R K Berge; A Nordøy; K H Bønaa
Journal:  Lipids       Date:  1998-11       Impact factor: 1.880

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.